lobbying_activities: 3059856

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3059856	3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c	Q3	MARSHALL & POPP, LLC	401105121	GENENTECH, INC.	2023	third_quarter	CPT	Issues related to intellectual property and patent reform, including: S.150, Affordable Prescriptions for Patients Act; S.79, Interagency Patent Coordination and Improvement Act; S.113, Prescription Pricing for the People Act; S.142, Preserve Access to Affordable Generics and Biosimilars Act; and S.148, Stop STALLING Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2023-10-19T09:48:22-04:00